Sarepta Therapeutics Inc (SRPT) Price

Sarepta Restructures Debt Amid ELEVIDYS Pressure

Sarepta Therapeutics is exchanging convertible notes to extend its debt maturity. The move comes as it navigates a new FDA boxed warning and restricted label for its key gene therapy, ELEVIDYS, following serious safety events.